Meanwhile, drug pricing is fracturing Republicans
At the outset of 2019, reducing the cost of medicine was virtually the only idea in Washington with bipartisan support. Now that the year’s winding down, it’s dividing individual parties.
As STAT’s Nicholas Florko reports, powerful Republicans are frustrated with Senate Majority Leader Mitch McConnell, who has stalled in scheduling a sweeping drug pricing bill for a vote. The legislation, which would cap the amount seniors can pay each year on drugs and would block drug makers from raising their prices more than inflation, passed the Senate Finance Committee in July but has since gone nowhere.
“The president wants it,” said Sen. Chuck Grassley, the Iowa Republican who chairs the finance committee. “Senate majority leaders, historically, if you’ve got the president of the same party, they tend to be spokesmen for the administration, not against the administration.”
Read more.
As STAT’s Nicholas Florko reports, powerful Republicans are frustrated with Senate Majority Leader Mitch McConnell, who has stalled in scheduling a sweeping drug pricing bill for a vote. The legislation, which would cap the amount seniors can pay each year on drugs and would block drug makers from raising their prices more than inflation, passed the Senate Finance Committee in July but has since gone nowhere.
“The president wants it,” said Sen. Chuck Grassley, the Iowa Republican who chairs the finance committee. “Senate majority leaders, historically, if you’ve got the president of the same party, they tend to be spokesmen for the administration, not against the administration.”
Read more.
.png)
No hay comentarios:
Publicar un comentario